DAFALGAN i.v. solution perfusion 1 g/100ml 10 pce
7680667020028
CH-66702
N02BE01
01.01.
Active substances:
Fiches Amavita / Sun Store / Coop Vitality
Details
- Product number
- 6670201
- CPT
- -
- Packaging group
- 10
- Unit
- Beutel
- Composition
- paracetamolum 1 g, hydroxypropylbetadexum 300 mg, dinatrii edetas, natrii chloridum, natrii dihydrogenophosphas dihydricus, dinatrii phosphas dihydricus, aqua ad iniectabile ad solutionem pro 100 ml corresp. natrium 247 mg.
Articles (1)
Dafalgan i.v. 1 g, Infusionslösung
Infusionslösung
10
Official Swissmedic V2 data
Additional information from the official database
Official medical documents
Detailed composition
| Substance | Quantity | Type | Category |
|---|---|---|---|
|
paracetamolum
|
1.0 G | Substance | Wirkstoff (Principe actif) |
|
hydroxypropylbetadexum
|
300.0 MG | Substance | HBESI |
|
dinatrii edetas
|
- | Substance | HNIDK |
|
natrii chloridum
|
- | Substance | HNIDK |
|
natrii dihydrogenophosphas dihydricus
|
- | Substance | HNIDK |
|
dinatrii phosphas dihydricus
|
- | Substance | HNIDK |
|
aqua ad iniectabile
|
- | Substance | HNIDK |
|
natrium
|
247.0 MG | Substance | HBESI |
Authorization holder
UPSA Switzerland AG
6300 Zug
Authorization information
- Swissmedic authorization number
- 66702
- Drug name
- Dafalgan i.v. 1 g, Infusionslösung
- Galenic form
- LSINF
- ATC Code
- N02BE01
- Authorization status
- Z
- Dispensation category
- B
- First authorization
- 30/11/2017
- Authorization expiration date
- 31/12/9999
- IT number
- 01.01.
- Domain
- Human medicine
Packaging details
- Description (FR)
- DAFALGAN i.v. solution perfusion 1 g/100ml 10 pce
- Description (DE)
- DAFALGAN i.v. Infusionslösung 1 g/100ml 10 Stk
- Market launch
- 30/11/2017
- Narcotic (BTM)
- No